================================================================================
MEDLESS V1 - MEDICATION DATA QUALITY AUDIT
================================================================================

ðŸ“Š OVERALL STATISTICS
--------------------------------------------------------------------------------
Total Medications:                343
With half_life_hours:             339 (98.8%)
With CYP data:                    303 (88.3%)
With withdrawal_risk_score:       343 (100.0%)
With category_id:                 343 (100.0%)
With therapeutic_range:           1 (0.3%)

ðŸš¨ DATA QUALITY ISSUES
--------------------------------------------------------------------------------

1. MISSING half_life_hours: 0 medications

2. INVALID half_life_hours: 4 medications (0 or >1000h)
   - ID 255: Hydroxychloroquin              half_life=1200h
   - ID 269: Alendronat                     half_life=87600h
   - ID 270: Risedronat                     half_life=43800h
   - ID 352: Cholecalciferol                half_life=1200h

3. MISSING/UNCLEAR CYP data: 40 medications
   Sample (first 10):
   - ID  19: Aspirin                        cyp='Schnelle Deacetylierung zu Salicylat, keine dominante CYP-AbhÃ¤ngigkeit'
   - ID  24: Tavor                          cyp='Glucuronidierung (kaum CYP)'
   - ID  44: Ventolin                       cyp='Geringe CYP-Beteiligung, v.a. Sulfatkonjugation'
   - ID  56: Lorazepam (Tavor)              cyp='Glucuronidierung (kaum CYP)'
   - ID  57: Temazepam (Remestan)           cyp='Glucuronidierung (nicht CYP)'
   - ID  61: Lormetazepam (Noctamid)        cyp='Glucuronidierung (nicht CYP)'
   - ID  98: Ramipril                       cyp='Lebermetabolismus (Esterhydrolyse zu Ramiprilat)'
   - ID 105: Liothyronin                    cyp='Keine relevante CYP-Beteiligung'
   - ID 106: Novothyral                     cyp='Keine relevante CYP-Beteiligung'
   - ID 135: Dimetinden                     cyp='Lebermetabolismus (kein dominanter CYP-Typ)'
   ... and 30 more

4. MISSING withdrawal_risk_score: 0 medications

5. MISSING category_id: 0 medications

6. SUSPICIOUS: High-dependency meds with withdrawal_score=0: 0

================================================================================
ðŸ“‹ CATEGORY-SPECIFIC CRITICAL FIELDS ANALYSIS
================================================================================

Category 2: Antidepressiva (trizyklisch)
  Total medications: 5
  Critical fields: withdrawal, cyp, half_life

Category 3: Antikonvulsiva
  Total medications: 17
  Critical fields: withdrawal, half_life

Category 5: Antipsychotika
  Total medications: 13
  Critical fields: withdrawal, cyp, half_life

Category 15: ADHS-Medikamente
  Total medications: 3
  Critical fields: withdrawal

Category 16: Hypnotika (Schlafmittel)
  Total medications: 18
  Critical fields: withdrawal, half_life

Category 17: Anxiolytika (Benzodiazepine)
  Total medications: 10
  Critical fields: withdrawal, half_life

Category 18: Opioide
  Total medications: 15
  Critical fields: withdrawal, cyp, half_life

Category 25: Antidepressiva (SSRI/SNRI)
  Total medications: 22
  Critical fields: withdrawal, cyp, half_life

Category 6: Statine
  Total medications: 6
  Critical fields: cyp

Category 19: Antihypertensiva
  Total medications: 23
  Critical fields: half_life

Category 24: Antikoagulantien
  Total medications: 6
  Critical fields: cyp, half_life

Category 8: Immunsuppressiva
  Total medications: 9
  Critical fields: cyp, half_life, withdrawal

Category 21: Corticosteroide
  Total medications: 5
  Critical fields: withdrawal, half_life

Category 26: HormonprÃ¤parate
  Total medications: 13
  Critical fields: cyp, half_life

================================================================================
ðŸ’¡ RECOMMENDATIONS
================================================================================

PRIORITY 1 (CRITICAL - Affects calculation):
  - Fix missing half_life_hours (used in Phase 3 reduction calculation)
  - Complete withdrawal_risk_score (used in Phase 6 reduction calculation)
  - Review CYP enzyme data (used in Phase 4 CYP adjustment)

PRIORITY 2 (HIGH - Improves safety):
  - Review zero withdrawal scores for high-dependency meds
  - Verify invalid half-life values (0h or >1000h)

PRIORITY 3 (MEDIUM - Future features):
  - Add therapeutic_min/max ranges for narrow-window drugs
  - Complete category_id for any uncategorized medications

================================================================================
âœ… EXPORT LISTS FOR MANUAL REVIEW
================================================================================

Medications needing half_life_hours:


Medications needing withdrawal_risk_score:


Medications needing CYP clarification:
19,24,44,56,57,61,98,105,106,135,136,151,159,195,211,266,279,282,284,285,286,295,296,298,314,323,333,339,343,346,347,348,352,355,359,362,363,365,368,369

